Clinical Terminal

Funding & M&A

Rounds, acquisitions, and the investors moving capital across the revenue cycle.

26 stories
Current Surgical raises $9.5M for AI-powered cancer treatment platform
2d

Current Surgical raises $9.5M for AI-powered cancer treatment platform

Current Surgical has closed an oversubscribed $9.5 million Seed+ funding round, investor Wavemaker Three-Sixty Health announced in a LinkedIn post.

By Victoria Shi · AI Funding Reporter · November 20, 2026

3d

Valo Health and Montai Therapeutics Merge to Form AI-Powered Drug Discovery Company

Valo Health and Montai Therapeutics Merge to Form AI-Powered Drug Discovery Company

Valo Health and Montai Therapeutics, two companies founded by Flagship Pioneering, have merged to create a unified drug discovery platform, the companies announced. The combined entity will operate under the name Valo Health. Financial terms of the merger were not disclosed, according to a Dealroom.co report.

Victoria Shi · AI Funding Reporter · November 18, 2026

3d

Windward Bio Raises $251.2M in Nasdaq IPO and Private Placement

Windward Bio Raises $251.2M in Nasdaq IPO and Private Placement

Swiss biotech company Windward Bio has raised approximately $251.2 million through an initial public offering and a concurrent private placement, according to a report from investing.com.

Victoria Shi · AI Funding Reporter · November 18, 2026

4d

Vumedi Announces $104M Series B for AI-Powered Physician Learning Platform

Vumedi Announces $104M Series B for AI-Powered Physician Learning Platform

Vumedi, a peer-to-peer video learning platform for physicians, has received a $104 million Series B growth investment from Oak HC/FT. The company announced the funding on November 10, 2026, in a press release.

Victoria Shi · AI Funding Reporter · November 18, 2026

4d

ŌURA to Acquire AI Primary Care Company Counsel Health for $625M

ŌURA to Acquire AI Primary Care Company Counsel Health for $625M

Smart ring maker ŌURA announced on November 10, 2026, that it has agreed to acquire AI-powered primary care company Counsel Health for $625 million in an all-cash deal. The transaction is expected to close before the end of 2026, subject to customary closing conditions, according to company statements.

Victoria Shi · AI Funding Reporter · November 18, 2026

4d

Credo Health Acquires Affineon, Relaunches as Pajama.ai to Cut Doctor Workload

Credo Health Acquires Affineon, Relaunches as Pajama.ai to Cut Doctor Workload

Denver-based healthcare AI company Credo Health has acquired Affineon Health and relaunched the combined enterprise as Pajama.ai, the companies announced. Financial terms of the acquisition were not disclosed, according to multiple reports.

Victoria Shi · AI Funding Reporter · November 18, 2026

4d

Commure Acquires Elaborate to Automate Clinician Inbox Management

Commure Acquires Elaborate to Automate Clinician Inbox Management

Commure, a healthcare AI platform, announced on Nov. 16 that it has acquired Elaborate, a clinical intelligence company that automates clinician inboxes. The financial terms of the transaction were not disclosed, according to company announcements.

Victoria Shi · AI Funding Reporter · November 18, 2026

More Funding & M&A

19

The Deal Sheet · recent rounds & exits

Company
Type
Amount
Date
Waystar ← Iodine
Acquisition
$1.25B *
2026
Candid Health
Series C
$52.5M
Feb 2025
Candid Health
Series B
$29M
Sep 2024
Candid Health
Seed
$18M
2020
R1 ← Phare Health
Acquisition
Undisclosed
2026

* sourced to headline; not independently verified. Source: knowledge_graph.edges_investment + clustered M&A signals.